vimarsana.com

Latest Breaking News On - Vice president marco krieger - Page 1 : vimarsana.com

Diplomatic rift with China results in shortage of active ingredient to produce vaccines in Brazil

All it takes for China to resume shipping IFA is an apology from Bolsonaro São Paulo Governor Joao Doria Friday blamed Brazilian President Jair Bolsonaro for a diplomatic crisis with China, which led to the suspension of supplies to manufacturing vaccines against the coronavirus. The Butantan Institute, which depends from the state of São Paulo, Friday stopped manufacturing the Coronavac immunizer due to the lack of Active Pharmacological Input (IFA), it was announced. Doria said that there was “a diplomatic friction caused by disastrous statements by the federal government against the government of China and against the vaccine itself.”

Brazil eyes July for full local production of AstraZeneca vaccine

3 Min Read RIO DE JANEIRO (Reuters) - Brazil could begin full production of AstraZeneca Plc’s COVID-19 vaccine by July if regulators allow, an official at biomedical center Fiocruz said, moving up by 100 days the timeline to produce shots without imported ingredients. FILE PHOTO: A healthcare worker holds a vial of the AstraZeneca/Oxford coronavirus disease (COVID-19) vaccine at a public hospital in Rio de Janeiro, Brazil, January 27, 2021. REUTERS/Pilar Olivares Fiocruz Vice President Marco Krieger told Reuters that, if health regulator Anvisa waives some controls, the biomedical institute could move up the Sept. 30 target date for 100% local production of the shot by AstraZeneca and Oxford University.

Brazil eyes July for full local production of AstraZeneca vaccine

Brazil eyes July for full local production of AstraZeneca vaccine Reuters 3/15/2021 By Rodrigo Viga RIO DE JANEIRO (Reuters) - Brazil could begin full production of AstraZeneca Plc s COVID-19 vaccine by July if regulators allow, an official at biomedical center Fiocruz said, moving up by 100 days the timeline to produce shots without imported ingredients. Fiocruz Vice President Marco Krieger told Reuters that, if health regulator Anvisa waives some controls, the biomedical institute could move up the Sept. 30 target date for 100% local production of the shot by AstraZeneca and Oxford University. This would be important at a time when Brazil is facing vaccine shortages, Krieger said in an interview on Friday.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.